| Accession Number: | 0001439222-22-000001 |
| Date: | 2022-01-06 |
| Issuer: | AGIOS PHARMACEUTICALS, INC. (AGIO) |
| Original Submission Date: |
CAR BRUCE
C/O AGIOS PHARMACEUTICALS, INC.
88 SIDNEY STREET
CAMBRIDGE, MA 02139
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2022-01-06 | M | 3,437 | a | $0.00 | 10,530 | direct | ||
| COMMON STOCK | 2022-01-06 | F | 1,205 | d | $32.58 | 9,325 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RESTRICTED STOCK UNITS | 0.0 | 2022-01-06 | deemed execution date | M | 3,437 (d) | common stock 3,437 | $0.00 | 3,437 | direct |
| ID | footnote |
|---|---|
| f1 | each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. |
| f2 | the restricted stock units were granted on january 6, 2020. beginning on january 6, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. |
